Antigen rapid tests: training package
The SARS-CoV-2 antigen rapid diagnostic test (SARS-CoV-2 Ag RDT) training package is a structured comprehensive collection of training resources and tools to support relevant institutions to organize, run and evaluate training of trainers and/or training of health workers who will be performing SARS-CoV-2 testing using Ag RDTs.
The training package can be used in face-to-face training or as a blend of remote face-to-face training. Materials can be adapted and customized based on national guidelines and target group of participants.
The training addresses the theoretical and practical components of SARS-CoV-2 Ag RDT testing and provides trainees with the skills and resources on how to safely perform SARS-CoV-2 Ag RDT tests. It does not intend to address the implementation of Ag RDT testing across the diagnostic network.
The SARS-CoV-2 Ag RDT v1.0 training package has been designed and developed by FIND and WHO.
SARS-CoV-2 Ag RDT training package v1.0
Sharing feedback on the use of these materials will help us improve them. Please click on the following link to provide such feedback. If you have queries or need additional information, please contact us here.
Guidance for facilitators
- Trainers guide (word file – 161 KB)
Additional materials for facilitators
- Checklist of training materials (word file – 36 KB)
- FAQ (word file – 48 KB)
- Competency assessment (word file – 115 KB)
- Certificate template (ppt file – 43 KB)
- Training evaluation form (word file – 43 KB)
|Personal protective equipment (PPE) training video (zip file – 26.8 MB)|
|How to do a SARS-CoV-2 antigen rapid diagnostic test (zip file – 104 MB)|
WHO Health Security Learning Platform – Training Materials
These WHO Training Materials are ©World Health Organization (WHO) 2020. All rights reserved.
Should you adapt, modify, translate, or in any other way revise the contents of these materials, you shall not imply that WHO is any way affiliated with such modifications and shall not use the WHO name or emblem in such modified materials.
Further, please inform WHO of any modifications of these materials that you use publicly, for record-keeping purposes and continued development, by emailing email@example.com.